Enanta Pharmaceuticals (ENTA) Asset Utilization Ratio (2013 - 2026)

Enanta Pharmaceuticals' Asset Utilization Ratio history runs 14 years deep, the most recent figure standing at 0.21 for Q1 2026.

• Quarterly Asset Utilization Ratio rose 11.94% year-over-year to 0.21 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.21 (up 11.94% YoY) and the FY2025 annual result came in at 0.2, up 23.26% from the prior year.
• Asset Utilization Ratio was 0.21 for Q1 2026 at Enanta Pharmaceuticals, down from 0.22 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.24 in Q1 2023 and bottomed at 0.17 in Q4 2023.
• A 5-year average of 0.2 and a median of 0.21 in 2025 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2024 — Asset Utilization Ratio dropped 28.14% — and 2025, when it advanced 28.74%.
• Enanta Pharmaceuticals' Asset Utilization Ratio stood at 0.23 in 2022, then declined by 27.22% to 0.17 in 2023, then advanced by 11.09% to 0.18 in 2024, then gained by 19.55% to 0.22 in 2025, then retreated by 2.12% to 0.21 in 2026.
• Business Quant data shows ENTA's Asset Utilization Ratio at 0.21 in Q1 2026, 0.22 in Q4 2025, and 0.22 in Q3 2025.